Alto Neuroscience(US:ANRO) Globenewswire·2025-10-03 14:51Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims against Alto Neuroscience, Inc. officers and directors for possible breaches of fiduciary duties [1] Group 1: Allegations of Misconduct - A federal securities fraud class action complaint has been filed against Alto Neuroscience, Inc., alleging that the company made materially false and misleading statements regarding its business and operations [2] - The complaint specifically claims that ALTO-100 was less effective in treating Major Depressive Disorder (MDD) than represented, and that the clinical, regulatory, and commercial prospects of ALTO-100 were overstated [2] - As a result of these misrepresentations, the company's business and financial prospects were also overstated, leading to materially false public statements [2] Group 2: Actions for Shareholders - Shareholders may pursue changes to the company's corporate governance practices, seek recovery of funds, and request a court-approved incentive award at no cost [3] - Interested parties can join the action through a provided link or by contacting Johnson Fistel, PLLP directly [3] Group 3: About the Law Firm - Johnson Fistel, PLLP is a nationally recognized law firm that represents individual and institutional investors in shareholder derivative and securities class action lawsuits [4]